Lester Lien, PhD (Observer)
Investment Partner, Pac-Link BioVentures

Mr. Lien has been an Investment Partner of Pac-Link BioVentures, a venture capital firm, since 2005. Dr. Lien oversees Pac-Link’s healthcare portfolio in the U.S. including recent investments in Bayhill Therapeutics, Globeimmune, Fibrogen, and Trellis Bioscience. Dr. Lien also serves as board observer of Broncus Technologies and Epitomics. Previously, Dr. Lien held the position of Investment Director of PRM Ventures and Investment Manager at CX Ventures. Mr. Lien received his BS in Biochemical Sciences from Harvard College and earned his PhD in Molecular Genetics from Harvard University.